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. The percentage of reads mapped to ERCC transcripts, rat rRNA, AceView genes, and genomic regions. The proportions of reads mapped (ratio, Mean ± SE; N=16 in uterus and testes, N=32 in the other 9 organs) to AceView exons (green), ERCC transcripts (orange), genomic regions (blue), and rRNA (pink) in each organ. Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lng, lung; Lvr, liver; Msc, skeletal muscle; Spl, spleen; Thm, thymus; Tst, testis; and Utr, uterus.
Supplementary Figure S3. The distribution of the pair-wise correlation (R) between any two biological replicates of the same condition (same organ x age x sex). Y-axis represents squared
Pearson correlation between any two biological replicates (log 2 FPKM). X-axis represents a total of 6*80=480 values in 11 organ types. There are four biological replicates for each of the 80 sample groups in this study, resulting in six pairwise comparisons of biological replicates per sample group. Figure S4 . ERCC performance in this study. (a) Scatterplot of averaged log 2 (FPKM) across 160 samples spiked with ERCC mixture 1 vs. log 2 (spike-in concentrations); (b) Scatterplot of averaged log 2 (FPKM) across 160 samples spiked with ERCC mixture 2 vs. log 2 (spike-in concentrations); (c) Averaged expression value of 92 ERCC transcripts for each of the 320 samples. Y-axis represents the averaged log 2 (FPKM) and X-axis represents 320 samples in this study. Figure S5 . Mapping pipeline. In total, 320 samples together with technical replicates were used in this study. Data were first trimmed using Trimmomatic. We used the rat transcriptome from AceView v08, which includes 40,064 genes, as a reference. In addition, the UCSC rn4 rat genome was used as a reference genome. Reads were aligned to the rat genome and transcriptome using TopHat v2.0.4 allowing a maximum of 2 mismatches in the alignment. The default parameter settings were used. Alignment results were then processed using Cufflinks for gene/transcript assembly and quantification. For samples with 2-3 technical replicates, averaged FPKM (Fragment Per Kilobase per Million mapped reads) values were used. To avoid infinite values, a pseudo-count of one was added to the FPKM value of each gene before log 2 transformation. Figure S6 . Workflow to identify organ-enriched genes. A total of 320 samples were separated into 11 groups based on organ. Differentially expressed gene analysis was performed by pair-wise comparison of any 2 of the 11 organs. A gene was defined as organ-enriched if its expression level was at least 2-fold higher than that in any other organ, using a Bonferroni-corrected p ≤ 0.05 across the four developmental stages. Figure S7 . Brain-enriched genes were involved in the role of CDK5 in presynaptic signaling. Genes identified as specifically enriched in the brain were uniquely overrepresented in the cyclindependent kinase 5 (CDK5) presynaptic signaling pathway map from Thompson Reuters Canonical Pathway Maps ontology. Enriched genes were highlighted with red thermometers on the map. CDK5 is a member of the small serine/threonine cyclin-dependent kinase family. CDK5 and its neuronspecific activator, cyclin-dependent kinase 5 regulatory subunit 1 (CDK5R1 (p35)), are all abundantly expressed in the adult brain. Moreover, they are present in subcellular fractions enriched for synaptic membranes, and localize to pre-and post-synaptic compartments, thus they can regulate both pre-and post-synaptic functions.
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Supplementary Figure S8 . Liver-enriched genes were involved in bile acid biosynthesis pathway. Genes identified as specifically enriched in the liver were uniquely overrepresented on the bile acid biosynthesis pathway map from Thompson Reuters Canonical Pathway Maps ontology. Enriched genes were highlighted with red thermometers on the map. Bile acids (BAs: cholic acid, deoxycholic acid, chenodeoxycholic acid, etc.) are amphipathic steroidal compounds derived from the enzymatic catabolism of cholesterol in hepatocytes. Figure S9 . Kidney-enriched genes were involved in renal secretion of organic electrolytes. Genes identified as specifically and uniquely enriched in the kidney were uniquely overrepresented in the renal secretion of organic electrolytes pathway map from Thompson Reuters Canonical Pathway Maps ontology. Enriched genes were highlighted with red thermometers on the map. Renal secretion of organic cations (including bases) and organic anions (including acids) has physiological, pharmacological, and toxicological importance. The proximal tubule is the primary site of renal electrolyte secretion. Figure S10 . Scheme for identifying sex-specific genes in each organ at each developmental stage. All 288 samples from 9 organs (except uterus and testis) were used to identify sexspecific genes. For each organ, samples were separated into four groups on the basis of developmental stage. Fold change and t-test p-value were calculated between males and females in each organ across the four stages. Sex-specific genes were those that had a fold change ≥ 2 (or ≤0.5) and p-value ≤ 0.05 for any organ at any development stage. Figure S11 . Sex-specific alternatively spliced variant expression of Ugt1a in rats. Bars: expression (log 2 FPKM, Mean ± SE; N=16 in uterus and testes, N=32 in the other 9 organs) of gene Ugt1a (upper), its isoform g (middle) and isoform h (bottom) in each organ in females (red) and males (blue). Stars: sex-specific (female > male, red; female < male, blue) and differently expressed in the organ. For any given organ and transcript variant, a gene/transcript variant with an FC between males and females ≥ 2 (or ≤ 0.5) with a p-value ≤ 0.05 (Student's t-test) was considered as a sex-specific gene/transcript variant. Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lvr, liver; Lng, lung; Msc, skeletal muscle; Spl, spleen; Tst, testis; Thm, thymus; and Utr, uterus. Figure S12 . Expression of spliced noncoding genes in AceView. (a) Distribution of 2,367 spliced noncoding genes based on gene expression level. (b) Cross-organ distribution of 139 organ-enriched noncoding genes. A gene that was expressed at FPKM ≥ 1 in all eleven organs, across all four developmental stages, in both males and females was defined as a commonly-expressed gene. A gene that was FPKM<1in all eleven organs, across all four developmental stages in both males and females, was defined as a "low" expressed gene. Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lvr, liver; Lng, lung; Msc, skeletal muscle; Spl, spleen; Tst, testis; Thm, thymus; and Utr, uterus.
Supplementary Figure S13. Expression profile of the spliced novel non-coding gene soyshee. Y-axis
shows the log 2 FPKM expression level (Mean ± SE; N=4). Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lvr, liver; Lng, lung; Msc, skeletal muscle; Spl, spleen; Tst, testis; Thm, thymus; and Utr, uterus.
Supplementary Figure S14. Expression of the Pecr gene and its alternatively spliced variants in rats.
The Y-axis represents the Z-score (Mean 0, SD 1) of log 2 FPKM (Mean ± SE; N=16 in uterus and testes, N=32 in the other 9 organs) and the X-axis shows the Pecr gene and its transcript variant Pecr.a, Pecr.c, and Pecr.d (Pecr gene in green; Pecr.a in orange; Pecr.c in blue; and Perc.d in pink) in each organ. Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lvr, liver; Lng, lung; Msc, skeletal muscle; Spl, spleen; Tst, testis; Thm, thymus; and Utr, uterus. Supplementary Table S1 . Significantly enriched GeneGo canonical pathway maps based on the commonly-expressed genes in all organs across the developmental stages. *The enrichment analysis was performed using a hypergeometric test to find over-representation of genes.
Supplementary Tables
Only statistically significant pathways with p-values < 0.05 were considered. The Benjamini-Hochberg FDR method was used to adjust the p-values for multiple testing.
Supplementary Table S3 . The most characteristic pathways and biological processes identified in organenriched genes.
Tissue Characteristic pathways and processes
Brain
Neurophysiological processes: dopamine signaling, CDK5 signaling, GABA signaling.
Adrenal gland Pathways dominated by those involving biosynthesis and metabolism, e.g. metabolism of catecholamines.
Heart
Significant pathways were associated with muscle contraction, signal transduction and regulation of cardiac hypertrophy.
Kidney
Top pathways were associated with regulation of renal functions, e.g. secretion of drugs. Other pathways included those associated with metabolism.
Liver
Significant pathways were associated with various metabolic processes e.g. fatty acid oxidation, bile acid biosynthesis.
Lung
Top pathways were directly associated with cell adhesion e.g. endothelial cell contacts. Other developmental pathways were also present, e.g. BMP signaling and NOTCH induced EMT.
Muscle
Significant pathways were mostly enriched for processes involving glycolysis and gluconeogenesis, and also regulation of acetly CoA carboxylase 2 activity in muscle.
Spleen
Significant pathways were mostly enriched for those associated with immune response.
Testes
Significant pathways were associated with glutathione metabolism.
Thymus
Significant pathways were associated with various immune related processes and signaling pathways.
Uterus
Significant pathways were associated cytoskeletal removeling and developmental processes.
In general, selection and ranking of the pathways was highly consistent with the organ function. Conversely, genes defined as commonly-expressed tended to be enriched in non-organ specific pathways. 
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